BMJ:植物性脂肪增加冠状动脉疾病患者死亡风险

2013-02-17 BMJ 医学论坛网 小康

美国国立卫生研究所的Ramsden等的研究表明,富含多不饱和脂肪酸的亚油酸干预性饮食增加冠状动脉疾病患者全因死亡率。研究论文2月5日发表于《英国医学杂志》(BMJ 2013,346:e8707)。 Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evalu

美国国立卫生研究所的Ramsden等的研究表明,富含多不饱和脂肪酸的亚油酸干预性饮食增加冠状动脉疾病患者全因死亡率。研究论文2月5日发表于《英国医学杂志》(BMJ 2013,346:e8707)。


Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis

Objective 
To evaluate the effectiveness of replacing dietary saturated fat with omega 6 linoleic acid, for the secondary prevention of coronary heart disease and death.
Design 
Evaluation of recovered data from the Sydney Diet Heart Study, a single blinded, parallel group, randomized controlled trial conducted in 1966-73; and an updated meta-analysis including these previously missing data.
Setting 
Ambulatory, coronary care clinic in Sydney, Australia.
Participants 
458 men aged 30-59 years with a recent coronary event.
Interventions 
Replacement of dietary saturated fats (from animal fats, common margarines, and shortenings) with omega 6 linoleic acid (from safflower oil and safflower oil polyunsaturated margarine). Controls received no specific dietary instruction or study foods. All non-dietary aspects were designed to be equivalent in both groups.
Outcome measures 
All cause mortality (primary outcome), cardiovascular mortality, and mortality from coronary heart disease (secondary outcomes). We used an intention to treat, survival analysis approach to compare mortality outcomes by group.
Results 
The intervention group (n=221) had higher rates of death than controls (n=237) (all cause 17.6% v 11.8%, hazard ratio 1.62 (95% confidence interval 1.00 to 2.64), P=0.05; cardiovascular disease 17.2% v 11.0%, 1.70 (1.03 to 2.80), P=0.04; coronary heart disease 16.3% v 10.1%, 1.74 (1.04 to 2.92), P=0.04). Inclusion of these recovered data in an updated meta-analysis of linoleic acid intervention trials showed non-significant trends toward increased risks of death from coronary heart disease (hazard ratio 1.33 (0.99 to 1.79); P=0.06) and cardiovascular disease (1.27 (0.98 to 1.65); P=0.07).
Conclusions 
Advice to substitute polyunsaturated fats for saturated fats is a key component of worldwide dietary guidelines for coronary heart disease risk reduction. However, clinical benefits of the most abundant polyunsaturated fatty acid, omega 6 linoleic acid, have not been established. In this cohort, substituting dietary linoleic acid in place of saturated fats increased the rates of death from all causes, coronary heart disease, and cardiovascular disease. An updated meta-analysis of linoleic acid intervention trials showed no evidence of cardiovascular benefit. These findings could have important implications for worldwide dietary advice to substitute omega 6 linoleic acid, or polyunsaturated fats in general, for saturated fats.

    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
    2013-06-22 dmxmncxtdtdi

    bfbqiqqchnhp

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
    2013-06-22 yzwfhssrdrxr

    vzpfrelnqafe

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
    2013-05-13 gaoxiaoe
  6. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1983405, encodeId=7c4e198340540, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Jun 30 14:03:00 CST 2013, time=2013-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1745158, encodeId=81b01e451589e, content=<a href='/topic/show?id=bdc262694bb' target=_blank style='color:#2F92EE;'>#植物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62694, encryptionId=bdc262694bb, topicName=植物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Thu Oct 31 00:03:00 CST 2013, time=2013-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5803, encodeId=5d54580333, content=bfbqiqqchnhp, beContent=null, objectType=article, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=dmxmncxtdtdi, createdTime=Sat Jun 22 02:50:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=5800, encodeId=b3295800ce, content=vzpfrelnqafe, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yzwfhssrdrxr, createdTime=Sat Jun 22 01:52:00 CST 2013, time=2013-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847488, encodeId=572c184e488ff, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Mon May 13 03:03:00 CST 2013, time=2013-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1798919, encodeId=9bdc1e9891944, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Feb 01 14:03:00 CST 2014, time=2014-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1252855, encodeId=f76d12528550d, content=<a href='/topic/show?id=463230886b8' target=_blank style='color:#2F92EE;'>#冠状动脉疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30886, encryptionId=463230886b8, topicName=冠状动脉疾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1255431, encodeId=b81f12554312a, content=<a href='/topic/show?id=587f6339050' target=_blank style='color:#2F92EE;'>#死亡风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63390, encryptionId=587f6339050, topicName=死亡风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Tue Feb 19 06:03:00 CST 2013, time=2013-02-19, status=1, ipAttribution=)]